Canonical ingredient
Oxytocin
OXYTOCIN
18 linked products
Official identifiers
CAS 50-56-6ChEBI CHEBI:7872InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56InChIKey XNOPRXBHLZRZKH-DSZYJQQASA-NKEGG_COMPOUND C00746NHPID_ID 4889SMILES [H][C@@]1([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Names and synonyms
- Oxytocin (en)
- Oxytocine/Ocytocine (fr)
- Oxytocine (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
OXY-20
20 · UNIT · ML
OXY-20 NW
20 · UNIT · ML
OXYTO-SURE
20 · UNIT · ML
OXYTOCIN
20 · UNIT · ML
OXYTOCIN INJ
20 · UNIT · ML
OXYTOCIN INJ 10UNIT/ML USP
10 · UNIT · ML
OXYTOCIN INJ 20IU
20 · UNIT · ML
OXYTOCIN INJ 20IU/ML
20 · UNIT · ML
OXYTOCIN INJ SYNTHETIC 20IU/ML
20 · UNIT · ML
OXYTOCIN INJ SYNTHETIC 20UNIT/ML
20 · UNIT · ML
OXYTOCIN INJECTION
20 · UNIT · ML
OXYTOCIN INJECTION
20 · UNIT · ML
OXYTOCIN INJECTION
20 · UNIT · ML
OXYTOCIN INJECTION - IM IV 20 UNITS/ML
20 · UNIT · ML
OXYTOCIN INJECTION USP
10 · UNIT · ML
OXYTOCIN INJECTION USP - IM,IV,SC 20IU/ML
20 · UNIT · ML
OXYTOCIN INJECTION, USP
10 · UNIT · ML
OXYTOCIN INJECTION, USP
10 · UNIT · ML